|
![]() |
|||
|
||||
OverviewDraws on the experiences of patients, physicians, and researchers to explain the revolutionary development of immunotherapy as a treatment for cancer and how that information is being harnessed to create more effective patient therapies. Full Product DetailsAuthor: Charles GraeberPublisher: Scribe Publications Imprint: Scribe Publications ISBN: 9781925322484ISBN 10: 1925322483 Pages: 320 Publication Date: 08 January 2019 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: Available To Order ![]() We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviews`Only Graeber, one of America's greatest non-fiction writers, could take a subject so complex, dense and sprawling and turn it into a rollicking high-tension medical thriller. Masterful.' -Douglas Rogers, award-winning journalist and author of The Last Resort `A gripping chronicle of the 100-year overnight success of immunotherapy. For myself and millions of other cancer survivors, The Breakthrough is a book of immense and essential hope.' -Michael Fitzgerald, co-founder and CEO of Submittable and author of Radiant Days `There is no villain more ruthless than cancer, which has robbed us all of loved ones who had to endure untold suffering before they succumbed. But after decades of frustration and toil, scientists finally understand how to vanquish the disease by activating the human body's natural defences. The intimate stories behind this triumph lie at the heart of Charles Graeber's The Breakthrough, an expertly crafted and exhilarating account of life-saving ingenuity at its most dazzling. You will never encounter another book so incisive about the art of medical sleuthing, or so poetic about our innate drive to hold on to all that's beautiful in this world for as long as we can.' -Brendan I. Koerner, Wired contributing editor and author of The Skies Belong to Us `Lucid and informed ... Graeber gives readers a basis for both understanding the challenges involved and for cautious optimism that a cure can be found.' -Publishers Weekly `Graeber concisely reviews the science of cancer ... The risks of tinkering with an intricate immune system are obviously high, even perilous. But the potential reward is a cure. Exciting reading.' -Booklist `Imagine a vaccine that could cure cancer. As this book reports, that possibility may not be far off ... [T]he book offers hope for more effective treatments in the near future. A readable survey of the emerging field of immunotherapy in cancer treatment.' -Kirkus `In Mr Graeber's hands, the evolution of immuno-oncology is both captivating and heartbreaking.' -David A. Shaywitz, The Wall Street Journal Author InformationCharles Graeber is a contributing editor for Wired and a contributor to publications such as The New York Times, The New Yorker, GQ, Vogue, and many others. He has received many awards, and his work has been featured on NPR, CNN, the BBC, and numerous other media outlets. Tab Content 6Author Website:Countries AvailableAll regions |